ORLACCHIO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 10.331
AS - Asia 2.196
EU - Europa 1.978
SA - Sud America 340
AF - Africa 28
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.878
Nazione #
US - Stati Uniti d'America 10.304
SG - Singapore 1.367
UA - Ucraina 415
PL - Polonia 334
CN - Cina 296
BR - Brasile 295
DE - Germania 285
HK - Hong Kong 264
IE - Irlanda 222
FR - Francia 176
RU - Federazione Russa 136
IT - Italia 103
FI - Finlandia 95
VN - Vietnam 86
KR - Corea 84
GB - Regno Unito 81
SE - Svezia 57
NL - Olanda 28
AR - Argentina 22
BE - Belgio 20
BD - Bangladesh 19
JP - Giappone 16
ID - Indonesia 13
IN - India 12
EC - Ecuador 11
CA - Canada 10
MX - Messico 9
EG - Egitto 7
ES - Italia 7
AT - Austria 6
AE - Emirati Arabi Uniti 5
PK - Pakistan 5
ZA - Sudafrica 5
CL - Cile 4
IQ - Iraq 4
KE - Kenya 4
MA - Marocco 4
TN - Tunisia 4
UZ - Uzbekistan 4
CH - Svizzera 3
KG - Kirghizistan 3
LB - Libano 3
VE - Venezuela 3
AL - Albania 2
AU - Australia 2
CO - Colombia 2
DZ - Algeria 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
TH - Thailandia 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
LT - Lituania 1
NC - Nuova Caledonia 1
PH - Filippine 1
PS - Palestinian Territory 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TR - Turchia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 14.878
Città #
Woodbridge 2.526
Houston 1.802
Wilmington 1.411
Fairfield 796
Ann Arbor 655
Singapore 535
Jacksonville 403
Ashburn 349
Kraków 325
Cambridge 289
Seattle 287
Hong Kong 264
Dublin 222
Chandler 202
Medford 174
Beijing 145
Santa Clara 102
Lawrence 83
The Dalles 70
Dearborn 66
Menlo Park 49
San Diego 40
Los Angeles 39
Buffalo 37
New York 36
Mülheim 33
Ho Chi Minh City 30
London 24
Milan 24
Moscow 24
São Paulo 24
University Park 21
Zhengzhou 21
Mountain View 20
Norwalk 20
Munich 19
Verona 19
Falls Church 17
Chicago 16
Hanoi 16
Waanrode 16
Redondo Beach 14
Redwood City 13
Rome 13
Hefei 12
Nanjing 11
Rio de Janeiro 11
Dallas 10
Detroit 10
Turku 9
Jakarta 8
Warsaw 8
Boston 6
Brasília 6
Brooklyn 6
Curitiba 6
Dhaka 6
Saint Petersburg 6
Tokyo 6
Campinas 5
Columbus 5
Guangzhou 5
Indiana 5
Kunming 5
Mcallen 5
Miami 5
Osasco 5
Phoenix 5
Porto Alegre 5
Shanghai 5
Atlanta 4
Brussels 4
Cairo 4
Council Bluffs 4
Florianópolis 4
Fremont 4
Guayaquil 4
Hebei 4
Helsinki 4
Jinan 4
Johannesburg 4
Nairobi 4
Palo Alto 4
Santo André 4
Stockholm 4
Toronto 4
Belo Horizonte 3
Belém 3
Bologna 3
Fortaleza 3
Goiânia 3
Haiphong 3
Irecê 3
Islington 3
Joinville 3
Nuremberg 3
Orem 3
Prescot 3
San Francisco 3
Sorocaba 3
Totale 11.573
Nome #
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 506
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 492
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 489
Clinical and genetic study of a large SPG4 Italian family 483
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 470
Silver syndrome variant of hereditary spastic paraplegia: A locus to 4p and allelism with SPG4 431
Upper motor neuron involvement in X-linked recessive bulbospinal muscular atrophy 422
Association analysis between Alzheimer's disease and the Nicastrin gene polymorphisms 410
Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients 409
Association study of the 5-hydroxytryptamine(6) receptor gene in Alzheimer's disease 377
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment 375
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 374
SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis 372
A new SPG4 mutation in a variant form of spastic paraplegia with congenital arachnoid cysts 364
New locus for hereditary spastic paraplegia maps to chromosome 1p31.1-1p21.1 361
Therapy with drug product AZD-103 may ease Alzheimer’s disease 269
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 186
Late-onset spastic paraplegia: Aberrant SPG11 transcripts generated by a novel splice site donor mutation 184
Exome sequencing identifies a novel intronic mutation in ENG that causes recurrence of pulmonary arteriovenous malformations 183
Bridging Over the Troubled Heterogeneity of SPG-Related Pathologies: Mechanisms Unite What Genetics Divide 175
Neonatal SCA2 Presenting With Choreic Movements and Dystonia With Dystonic Jerks, Retinitis, Seizures, and Hypotonia 169
Up-regulation of glycohydrolases in Alzheimer's Disease fibroblasts correlates with Ras activation 165
A novel mutation in the SPG3A gene (atlastin) in hereditary spastic paraplegia 159
The role of reticulons in neurodegenerative diseases 155
Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE 151
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study 150
Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases 146
Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids 145
Absence of linkage between familial amyotrophic lateral sclerosis and copper chaperone for the superoxide dismutase gene locus in two Italian pedigrees 145
Alpha2-macroglobulin polymorphisms in Italian sporadic and familial Alzheimer's disease 141
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis 140
miR128 up-regulation correlates with impaired amyloid β(1-42) degradation in monocytes from patients with sporadic Alzheimer's disease 139
Autosomal recessive hereditary spastic paraplegia with thin corpus callosum: a novel mutation in the SPG11 gene and further evidence for genetic heterogeneity 138
Application of long-range polymerase chain reaction in the diagnosis of X-linked dystonia-parkinsonism 138
Late-onset hereditary spastic paraplegia with thin corpus callosum caused by a new SPG3A mutation 136
Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity 134
Late-onset CMT2 associated with a novel missense mutation in the cytoplasmic domain of the MPZ gene 132
Novel SPG6 mutation p.A100T in a Japanese family with autosomal dominant form of hereditary spastic paraplegia 132
Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS. 132
Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease 132
Oromandibular dystonia associated with SCA36 132
Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12 129
Effects of Vitamin C on Fibroblasts from Sporadic Alzheimer’s Disease Patients 128
RNA interference as a tool for Alzheimer's disease therapy 127
Hereditary spastic paraplegia: Clinical-genetic characteristics and evolving molecular mechanisms 127
Spastic paraplegia in Romania: high prevalence of SPG4 mutations 125
Research actuality in the genetics of stroke 124
Characterization of human Enah gene. 124
PS1 Alzheimer's disease family with spastic paraplegia: the search for a gene modifier 124
Lack of SOD1 gene mutations and activity alterations in two Italian families with amyotrophic lateral sclerosis 121
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients 120
Platelet glycohydrolase activities: characterization and release 120
Caspase 3 activation and PARP cleavage in lymphocytes from newborn babies of diabetic mothers with unbalanced glycaemic control 120
Nitric oxide depletion alters hematopoietic stem cell commitment toward immunogenic dendritic cells 120
Platelets release their lysosomal content in vivo in humans upon activation 120
Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1 119
Lysosomal β-galactosidase and β-hexosaminidase activities correlate with clinical stages of dementia associated with Alzheimer's disease and type 2 diabetes mellitus 118
Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis 117
MicroRNA Implications across Neurodevelopment and Neuropathology 116
Beta-N-acetylhexosaminidase in peripheral blood lymphocytes and monocytes in the different forms and stages of multiple sclerosis 115
Clinical and genetic study of a large Italian family linked to SPG12 locus 115
Development of a New Tool for 3D Modeling for Regenerative Medicine 114
Identification of maternal uniparental isodisomy of chromosome 10 in a patient with mitochondrial DNA depletion syndrome 114
Stem cells and neurological diseases 112
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 112
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease 111
Novel presenilin 1 mutations associated with early onset of dementia in a family with both early-onset and late-onset Alzheimer disease 109
Cathepsin D expression is decreased in Alzheimer's disease fibroblasts 108
The apolipoprotein E2 isoform is associated with accelerated onset of coronary artery disease in systemic lupus erythematosus 107
beta-hexosaminidase, alpha-D-mannosidase, and beta-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I 105
Constitutive expression of beta-N-acetylhexosaminidase in a microglial cell line: transcriptional modulation by lipopolysaccharide and serum factors 102
Lack of association between Alzheimer's disease and the promoter region polymorphisms of the nicastrin gene 100
Hexosaminidase in Trichinella spiralis is a single protein with alpha- and beta-subunits catalytic activities 98
Activity levels of a beta1,6 N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients 96
Non-replication of association between MAPT-SNCA synergistical interaction and susceptibility to Parkinson’s Disease in a southern European population 94
Purification and properties of human urinary beta-D-mannosidase 91
Alpha-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis 90
Polymorphisms in the MAPT gene and risk of Parkinson disease in a Greek population: A case-control study. 86
On the identification of two beta-D-mannosidase forms in human kidney and urine 84
Hereditary spastic paraplegia: clinical genetic study of 15 families 83
Promoter characterization and structure of the gene encoding mouse lysosomal alpha-d-mannosidase 81
Elevated beta-N-acetylhexosaminidase activity in focal dystonia fibroblasts 78
Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease 76
Totale 14.923
Categoria #
all - tutte 47.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021726 0 0 0 0 0 92 156 116 108 57 172 25
2021/2022735 18 120 20 23 39 60 43 30 44 45 47 246
2022/2023686 102 55 8 53 55 204 65 21 52 0 52 19
2023/2024152 19 7 9 5 18 34 5 3 5 1 1 45
2024/20252.123 31 480 200 90 23 56 158 47 164 143 426 305
2025/2026929 138 115 298 152 161 65 0 0 0 0 0 0
Totale 14.923